Search the Newsreel

ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise

ETFs Investing in COSCO SHIPPING Energy Transportation Co., Ltd. Class H Stocks

Citi Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Maintains Target Price $21

Citi has reiterated its Buy rating on Bausch + Lomb Corp. (BLCO.US) and maintained its target price at $21. This indicates a continued positive outlook from the firm regarding the company's stock performance.

Cisco vs. Broadcom: One Stock Looks Like the Better AI Play

Quick Read Broadcom's 23x P/E against 200%+ AI revenue growth undercuts Cisco's 26x for 15% total growth, making AVGO the sharper AI play over CSCO. Cisco's full-year AI orders hit $9.3 billion, nearly double its $5 billion target, as Chuck Robbins declares an AI-driven …

Axiscades Q1 Results: Net profit rises 17% YoY to ₹30.9 crore

Ck Life Sciences Int'l., (Holdings) - LSI - Stock Price & News

What Is Invesco (IVZ) Signaling With $3.2 Billion In New Real Estate Loans?

Invesco (NYSE: IVZ) reported a 112% surge in Invesco Real Estate loan commitments, reaching US$3.2 billion in H1 2026. This increase signals a strategic push into real estate credit, with a focus on multifamily and industrial properties across global markets. The move aligns with …

Sysco EVP Ronald Phillips sells $558k in company stock By Investing.com

Sysco's EVP and Chief Human Resources Officer, Ronald L Phillips, sold 6,652 shares of company stock across two transactions for approximately $558,166 on August 10 and 11, 2026. These sales, executed under a Rule 10b5-1 trading plan, followed his exercise of stock options for …

ETFs Investing in Banco Bilbao Vizcaya Argentaria, S.A. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of Banco Bilbao Vizcaya Argentaria, S.A. (BBVAE). The ETFs are sorted by market value and include details such as weight in the fund, issuer, management style, expense ratio, AUM, price, change, and 3-year …

Warner Bros. Discovery Stock (WBD) Opinions on Paramount Skydance Merger Delays

Bank Of Nova Scotia (TSX:BNS) Earnings Beat Hopes Put Valuation Back In Focus

How Investors Are Reacting To Scholar Rock (SRRK) Dual Fill-Finish Readiness Amid Ongoing FDA Review

(BBVA) Price Dynamics and Execution-Aware Positioning

Stock Traders Daily provides an AI-driven analysis of Banco Bilbao Vizcaya Argentaria S.a. (NASDAQ: BBVA), indicating strong sentiment across all time horizons. The analysis offers three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with support and resistance levels for various timeframes. The …

How Investors Are Reacting To Forte Biosciences (FBRX) Widening Losses But Slightly Improved Per-Share Results

Forte Biosciences reported increased net losses in Q2 and H1 2026 but saw a slight improvement in basic loss per share due to share count adjustments. The company's investment narrative is now heavily tied to its pending sale to argenx and the cash tender …

Oscar Health’s Q2 Earnings Call: Our Top 5 Analyst Questions

Oscar Health's Q2 Earnings Call: Our Top 5 Analyst Questions Oscar Health's second quarter saw results well above Wall Street's expectations, yet the market response was notably negative. Management credited disciplined pricing, technology-driven cost efficiencies, and strong execution in the individual health insurance market …

Summit Global Investments Makes New Investment in Sysco Corporation $SYY

Summit Global Investments recently acquired 22,316 shares of Sysco Corporation (NYSE:SYY) valued at approximately $1.865 million. This comes as Sysco reported strong quarterly results, exceeding EPS and revenue expectations. Analyst sentiment remains mixed, with the stock holding a consensus "Hold" rating and an average …

Oppenheimer Asset Management Inc. Invests $9.43 Million in Sysco Corporation $SYY

Oppenheimer Asset Management Inc. has acquired a new stake worth $9.43 million in Sysco Corporation (NYSE:SYY) during the second quarter. This investment is part of broader institutional interest in Sysco, with several other large investors also adjusting their positions in the company. Sysco recently …

Next Capital Management LLC Invests $1.51 Million in The Charles Schwab Corporation $SCHW

Next Capital Management LLC has acquired a new stake of 16,323 shares in The Charles Schwab Corporation (NYSE:SCHW), valued at approximately $1.51 million. This comes amidst other institutional investors modifying their holdings and a significant amount of insider selling, totaling over $41 million in …

Summit Global Investments Takes Position in Cisco Systems, Inc. $CSCO

Summit Global Investments recently acquired 19,330 shares of Cisco Systems, Inc. valued at approximately $2.27 million, making it a new position for the firm. This comes as institutional investors collectively own 73.33% of Cisco's stock. Despite strong fiscal fourth-quarter results and optimistic fiscal 2027 …

Oppenheimer Asset Management Inc. Invests $9.62 Million in MSCI Inc $MSCI

Oppenheimer Asset Management Inc. recently invested $9.62 million in MSCI Inc. by acquiring 17,171 shares during the second quarter. Institutional investors collectively own 89.97% of MSCI. Despite a modest miss on Q2 earnings and revenue, analysts generally maintain a "Buy" rating with a target …

Trifecta Capital Advisors LLC Acquires Shares of 11,535 Cisco Systems, Inc. $CSCO

Trifecta Capital Advisors LLC recently acquired 11,535 shares of Cisco Systems, Inc. (NASDAQ:CSCO) valued at approximately $1.36 million during the second quarter. This move comes as Cisco reported strong fiscal fourth-quarter results, with revenue up 17.6% year-over-year and adjusted EPS beating estimates, driven by …

SWS Partners Takes Position in Cisco Systems, Inc. $CSCO

SWS Partners has acquired a new stake of 26,634 shares in Cisco Systems, Inc. valued at approximately $3.13 million during the second quarter. Several other institutional investors also adjusted their positions in Cisco, which recently reported strong quarterly earnings and issued optimistic guidance for …

Mill Capital Management LLC Invests $9.85 Million in Boston Scientific Corporation $BSX

Mill Capital Management LLC has invested $9.85 million in Boston Scientific Corporation, acquiring 230,815 shares. Institutional investors collectively own 89.07% of the company's stock, and despite a recent growth slowdown in key businesses, analysts maintain a "Moderate Buy" consensus rating with an average price …

Northstar Group Inc. Makes New $1.14 Million Investment in Escalade, Incorporated $ESCA

Northstar Group Inc. has made a new investment of $1.14 million in Escalade, Incorporated (NASDAQ:ESCA), acquiring 60,500 shares. This investment gives Northstar Group a 0.44% stake in the company, with institutional investors collectively owning 65.22% of Escalade. The news comes after Escalade reported strong …

CSTL (CSTL) insider and family trusts detail planned and recent stock sales

A recent SEC Form 144 filing indicates a planned sale of 25,792 shares of CSTL common stock, valued at $763,959.04, by an insider and related family trusts, to be executed around August 14, 2026, through Goldman Sachs & Co. LLC. The filing also details …

Walleye Capital LLC Acquires Shares of 347,898 Tyra Biosciences, Inc. $TYRA

Walleye Capital LLC has acquired a new stake of 347,898 shares in Tyra Biosciences, Inc. (NASDAQ:TYRA), valued at approximately $11.1 million, bringing institutional ownership in the company to 84.14%. Despite the stock opening at $25.29, well below its 52-week high, analysts maintain a "Moderate …

Aebi Schmidt Holding AG (AEBI) Q2 Earnings and Revenues Beat Estimates

Aebi Schmidt Holding AG (AEBI) reported Q2 earnings of $0.14 per share and revenues of $496.41 million, both surpassing Zacks Consensus Estimates. The company's shares have risen 2.7% year-to-date, though underperforming the S&P 500. The stock currently holds a Zacks Rank #3 (Hold) based …

Deutsche Bank Aktiengesellschaft Reiterates Sell Rating for Antofagasta (LON:ANTO)

Deutsche Bank Aktiengesellschaft has reissued a "sell" rating for Antofagasta (LON:ANTO), setting a price target of GBX 3,400, which suggests a potential downside of 5.92%. This rating contributes to an overall "Reduce" consensus among analysts, with an average price target of GBX 3,843.75. The …

Walleye Capital LLC Buys Shares of 386,183 IDEAYA Biosciences, Inc. $IDYA

Walleye Capital LLC has acquired 386,183 shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) during the second quarter, a new stake valued at approximately $14.4 million. This purchase represents 0.44% of IDEAYA Biosciences. Despite a reported quarterly loss of $1.22 per share, institutional ownership of the …

Sysco (NYSE:SYY): A Dividend Quality Pick for Income-Focused Investors

Sysco (NYSE:SYY) is highlighted as a quality dividend pick due to its strong dividend rating of 7, profitability rating of 7, and health rating of 5, passing ChartMill's "Best Dividend" screen. The article details Sysco's dividend yield of 2.61%, consistent dividend history, and solid …

Forte Biosciences, Inc. (NASDAQ:FBRX) Given Average Recommendation of "Hold" by Brokerages

Forte Biosciences, Inc. (NASDAQ:FBRX) has received an average "Hold" rating from seven brokerages, with an average 12-month price target of $72.50, below its current $76.83 stock price. Recent analyst coverage has generally been negative, including downgrades from Wall Street Zen, Weiss Ratings, Barclays, and …

Dockside LLC Takes Position in MSCI Inc $MSCI

Dockside LLC has acquired a new stake in MSCI Inc, purchasing 6,832 shares valued at approximately $3.83 million, making MSCI 0.9% of its portfolio. This comes as MSCI faces mixed sentiment, with positive news from its August index review expected to drive rebalancing and …

Absci Corporation (NASDAQ:ABSI) Receives Consensus Rating of "Moderate Buy" from Analysts

Absci Corporation (NASDAQ:ABSI) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $13.43. Despite missing quarterly earnings and revenue estimates, institutional investors hold over 52% of the stock. The company leverages machine learning and synthetic biology in …

Bausch & Lomb (BLCO) director receives 11,776 RSU equity grant as compensation

Bausch & Lomb Corp director Robert J. Chersi received an equity compensation award of 11,776 restricted share units (RSUs) under the company's 2022 Omnibus Incentive Plan. These RSUs will vest immediately before the next annual meeting of shareholders and will be settled in common …

8 Green Days In A Row: Warner Bros. Discovery Stock Is Up 8.5%

Value Partners Investments Inc. Reduces Holdings in Thermo Fisher Scientific Inc. $TMO